§ Laura MoffattTo ask the Secretary of State for Health if it is his policy to provide recombinant (synthetic) clothing factors for new haemophilia patients and children under 16; and if it applies to the provision of Factor VIIa to patients with inhibitors, who are resistant to Factor VIII and IX. [35282]
§ Yvette CooperIn 1998 we notified health authorities that from 1998–99 all children under the age of 16 and new patients with haemophilia A should receive recombinant factor VIII. From April 1999 this policy was extended to recombinant factor IX for patients with haemophilia B. We have not issued any advice to health authorities on the treatment of patients with inhibitors, of which recombinant factor VIIa is one of a range of possible treatments. Guidance on overall management of these patients, including the use of recombinant factor VIIa, has however been issued by the United Kingdom Haemophilia Centre Doctors Organisation. A copy of these guidelines is available in the Library.